
Nephrologist

No OPD information available
Glomerulonephritis
IgA Nephropathy
Chronic Kidney Disease
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Goodpasture Syndrome
Type 2 Diabetes (T2D)
Wilson Disease
Anemia
Cerebral Hypoxia
End-Stage Renal Disease (ESRD)
Hypertension
Interstitial Nephritis
Kidney Transplant
Obesity
Peritonitis
Secondary Peritonitis
Muh G. Wong is a doctor who helps people with kidney and related health problems. Some of the things they specialize in are Glomerulonephritis, which is a kidney disease, and Diabetic Nephropathy, which affects kidneys in people with diabetes. They also work with conditions like Anemia, Hypertension (high blood pressure), and Type 2 Diabetes.
Muh G. Wong uses their special skills to treat patients with care and expertise. They may perform kidney transplants or help manage conditions like Chronic Kidney Disease. Patients trust Muh G. Wong because they communicate well and listen to their concerns. They make sure patients understand their treatment options and feel supported.
To stay updated with the latest medical knowledge, Muh G. Wong reads research papers and attends conferences. This helps them provide the best care based on new discoveries in the medical field. They also collaborate with other medical professionals to share knowledge and improve patient outcomes.
Muh G. Wong's work has positively impacted many patients' lives. For example, they may have helped someone with End-Stage Renal Disease get a kidney transplant, improving their quality of life. Their dedication to research and clinical trials, like the one involving daprodustat in peritoneal dialysis patients, shows their commitment to advancing kidney care.
In clinical trials, Muh G. Wong is studying a drug called Atrasentan for patients with proteinuric glomerular diseases. This research could lead to new treatments that benefit patients in the future. Overall, Muh G. Wong's expertise, communication skills, and dedication to improving kidney health make them a trusted and valuable healthcare provider in their field.
Enrollment Status: Active not recruiting
Published: January 30, 2025
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 2
